Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Virology Market Overview (2022-2032)

[250 Pages Report] The virology market is projected to register a CAGR of 5% during the forecast period, up from US$ 2.07 Billion in 2021, to reach a valuation of US$ 3.53 Billion by 2032.

The virology market is anticipated to rise significantly due to public awareness campaigns on the Flu, Zika virus, STDs, AIDS, and Ebola virus, during the forecast period (2022 to 2032).

Attributes Details
Virology Market Value (2021) US$ 2.07   Billion
Virology Market Value (2032) US$ 3.53 Billion
CAGR (2022 to 2032) 5%

The virology market is continually catering to the healthcare sector's preventive and cure demands; yet, some illnesses continue to need R&D of fresh applications, fueling the virology market growthVirology applications are also used in various therapies and diagnostic processes, fueling virology market expansion. 

Another factor driving the growth of the virology market and the demand for the virology process is the expanding applications of virology research in gene therapy, phage treatment, vaccine formulation, and synthetic biology.

Furthermore, the virology market is expanding in numerous forms, such as molecular virology, pediatric virology, computational virology, and many others, resulting in increased research discoveries during the projected period. The possibilities for research are promising, and it is predicted that continued demand for virology process and competent virologists in the foreseeable future.

Some of the vital virology market trends include antiviral therapy advancements in detection techniques, drugs, and vaccines are likely to boost the growth of the virology market. Global efforts are being made to develop innovative vaccines to propel the demand for virology processes and medications to treat virally resistant illnesses, thus promoting virology market growth. 

In Phase II studies, for example, Pritelivir, an experimental medicine for herpes simplex virus (HSV) by AiCuris, has proved to be particularly efficient compared to the current conventional antiviral therapies for genital herpes. Extensive research has been undertaken worldwide to treat high-epidemic viral diseases such as Ebola, Dengue, and Malaria.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Drivers of the Virology Market Share?

Modern technologies for identifying and treating viral illness are anticipated to aid global virology market growth

The virology market continually responds to the healthcare sector's preventative and curative demands.

However, various ailments necessitate R&D for innovative applications, propelling the virology market forward. Furthermore, public awareness campaigns on the Flu, Zika virus, STDs, AIDS, and Ebola virus are also significant factors responsible for increased demand of virology process and virology market growth.

Virology applications are also used in various therapies and diagnostic processes, supporting virology market expansion.

According to the World Health Organization (WHO), all kinds of influenza together create yearly epidemics of 3 to 5 million patients with a severe stage of disease, resulting in 290 000 to 650 000 fatalities globally each year. Although fast diagnostic tests in the virology process are the most often utilized, PCR-based approaches are employed to detect influenza.

Which Region holds the Highest Growth Potential in the Virology Market?

Due to technological advancements such as rapid, portable diagnostics, North America is the largest virology market, led by the United States. North America is likely to maintain its virology market leadership during the projection period (2022-2032), owing to a rapid rise in demand for the virology process.

Europe is expected to continue its position as the world's second-largest virology market. Europe is expected to have the greatest CAGR throughout the projected period, owing to improved healthcare infrastructure, easier access to diagnostics, increasing demand for virology process and rising affordability of diagnostic testing for viral infections.

Japan currently has a thriving virology market that is expected to expand at a phenomenal CAGR through 2032. During the projected period, APEJ and Africa are likely to have the most promising virology market growth potential. While China would be the main APEJ market, India will contribute significantly to the APEJ virology industry.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is the Competitive Landscape in the Virology Market?

GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche are among the key competitors in the global virology market.

The report consists of key players contributing to the virology Market share. This exclusive report analyzes the competitive landscape and virology Market share acquired by key players to strengthen their virology market position.

Recent Developments in the Virology Market

  • The generic competition in the virology market will be at a high pace from 2022 onward. By 2017 end, a few essential patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following the expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape of the virology market.  
  • Merck & Co. Inc. has many medication candidates in phase 2 for cancer, diabetes, cardiac arrest, and hepatitis C, as well as several candidates in phase 3 for breast cancer, atherosclerosis, Alzheimer's disease, ebola, and HIV. The firm also has many additional prospects that are now being evaluated.
  • Abivax, a well-known biotech firm based in Paris, France, has previously generated candidates against the dengue and chikungunya viruses. The business is now developing a couple of other options against HIV and Ebola.
  • Nanoscale viral trap molecule technology, which is currently being researched, may be useful in identifying viral sickness. 
  • A novel adjustable gadget selectively captures viruses, detecting them with 100 times the sensitivity of conventional approaches. 
  • Another nanoparticle-based medication under development to treat viral illness is DRACO (Double-stranded RNA Activated Caspase Oligomerizer)

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Scope Of Report

Report Attribute Details
Growth rate CAGR of 5% from 2022 to 2032
Base year for estimation 2021
Historical data 2015 to 2020
Forecast period 2022 to 2032
Quantitative units Revenue in USD million, and CAGR from 2022 to 2032
Report coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered Product, application, end user, region
Regional scope North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs.

Key Segments

By Product Type:

  • Diagnosing Test
  • Viral Infection Controlling Methods
  • Antiviral Chemotherapy
  • Interferons

By Application:

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Urinary Tract Infections
  • Eye Infections
  • CNS Infections
  • Sexually Transmitted Diseases
  • Perinatal Infections

By End User:

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centres
  • Blood Banks
  • Pharmacies

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the Growth Outlook for the Virology Market?

The virology market is likely anticipated to register a CAGR of 5% during the forecast period.

Who are the Key Players in the Virology Market?

Key players holding substantial virology market share include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

What is the Future of the Virology Market?

As per the analysis, the virology market share is likely to be US$ 3.53Bn by 2032.

Which is the Key Driver in the Virology Market?

Demand for virology process is anticipated to rise due to public awareness campaigns on diseases and modern technologies for identifying and treating viral illnesses.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Virology Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Instruments

        5.3.2. Assay Kits

        5.3.3. Consumables & Accessories

        5.3.4. Software & Data Management

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

Deep-dive segmentation will be available in the sample on request

6. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Disease Diagnosis

        6.3.2. Pharmaceuticals

        6.3.3. Virology Research

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

Deep-dive segmentation will be available in the sample on request

7. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

        7.3.1. Skin and Soft Tissue Infections

        7.3.2. Respiratory Tract Infections

        7.3.3. GI Tract Infections

        7.3.4. Urinary Tract Infections

        7.3.5. Eye Infections

        7.3.6. CNS Infections

        7.3.7. Sexually Transmitted Diseases

        7.3.8. Perinatal Infections

    7.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

Deep-dive segmentation will be available in the sample on request

8. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        8.3.1. Hospitals

        8.3.2. Clinics

        8.3.3. Laboratories

        8.3.4. Diagnostic Centers

        8.3.5. Blood Banks

    8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    8.5. Absolute $ Opportunity Analysis By End User, 2022-2032

Deep-dive segmentation will be available in the sample on request

9. Global Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Pacific

        9.3.6. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By Indication

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By Indication

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By Indication

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By Indication

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. U.K.

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By Indication

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By Indication

        12.3.5. By End User

    12.4. Key Takeaways

13. East Asia Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By Indication

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By Indication

        13.3.5. By End User

    13.4. Key Takeaways

14. South Asia & Pacific Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Thailand

            14.2.1.3. Indonesia

            14.2.1.4. Malaysia

            14.2.1.5. Singapore

            14.2.1.6. Australia

            14.2.1.7. New Zealand

            14.2.1.8. Rest of South Asia & Pacific

        14.2.2. By Product Type

        14.2.3. By Application

        14.2.4. By Indication

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By Indication

        14.3.5. By End User

    14.4. Key Takeaways

15. MEA Virology Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Application

        15.2.4. By Indication

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By Indication

        15.3.5. By End User

    15.4. Key Takeaways

16. Key Countries Virology Market Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2021

            16.1.2.1. By Product Type

            16.1.2.2. By Application

            16.1.2.3. By Indication

            16.1.2.4. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2021

            16.2.2.1. By Product Type

            16.2.2.2. By Application

            16.2.2.3. By Indication

            16.2.2.4. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2021

            16.3.2.1. By Product Type

            16.3.2.2. By Application

            16.3.2.3. By Indication

            16.3.2.4. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2021

            16.4.2.1. By Product Type

            16.4.2.2. By Application

            16.4.2.3. By Indication

            16.4.2.4. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2021

            16.5.2.1. By Product Type

            16.5.2.2. By Application

            16.5.2.3. By Indication

            16.5.2.4. By End User

    16.6. U.K.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2021

            16.6.2.1. By Product Type

            16.6.2.2. By Application

            16.6.2.3. By Indication

            16.6.2.4. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2021

            16.7.2.1. By Product Type

            16.7.2.2. By Application

            16.7.2.3. By Indication

            16.7.2.4. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2021

            16.8.2.1. By Product Type

            16.8.2.2. By Application

            16.8.2.3. By Indication

            16.8.2.4. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2021

            16.9.2.1. By Product Type

            16.9.2.2. By Application

            16.9.2.3. By Indication

            16.9.2.4. By End User

    16.10. China

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2021

            16.10.2.1. By Product Type

            16.10.2.2. By Application

            16.10.2.3. By Indication

            16.10.2.4. By End User

    16.11. Japan

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2021

            16.11.2.1. By Product Type

            16.11.2.2. By Application

            16.11.2.3. By Indication

            16.11.2.4. By End User

    16.12. South Korea

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2021

            16.12.2.1. By Product Type

            16.12.2.2. By Application

            16.12.2.3. By Indication

            16.12.2.4. By End User

    16.13. India

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2021

            16.13.2.1. By Product Type

            16.13.2.2. By Application

            16.13.2.3. By Indication

            16.13.2.4. By End User

    16.14. Thailand

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2021

            16.14.2.1. By Product Type

            16.14.2.2. By Application

            16.14.2.3. By Indication

            16.14.2.4. By End User

    16.15. Indonesia

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2021

            16.15.2.1. By Product Type

            16.15.2.2. By Application

            16.15.2.3. By Indication

            16.15.2.4. By End User

    16.16. Malaysia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2021

            16.16.2.1. By Product Type

            16.16.2.2. By Application

            16.16.2.3. By Indication

            16.16.2.4. By End User

    16.17. Singapore

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2021

            16.17.2.1. By Product Type

            16.17.2.2. By Application

            16.17.2.3. By Indication

            16.17.2.4. By End User

    16.18. Australia

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2021

            16.18.2.1. By Product Type

            16.18.2.2. By Application

            16.18.2.3. By Indication

            16.18.2.4. By End User

    16.19. New Zealand

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2021

            16.19.2.1. By Product Type

            16.19.2.2. By Application

            16.19.2.3. By Indication

            16.19.2.4. By End User

    16.20. GCC Countries

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2021

            16.20.2.1. By Product Type

            16.20.2.2. By Application

            16.20.2.3. By Indication

            16.20.2.4. By End User

    16.21. South Africa

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2021

            16.21.2.1. By Product Type

            16.21.2.2. By Application

            16.21.2.3. By Indication

            16.21.2.4. By End User

    16.22. Israel

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2021

            16.22.2.1. By Product Type

            16.22.2.2. By Application

            16.22.2.3. By Indication

            16.22.2.4. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Application

        17.3.4. By Indication

        17.3.5. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Thermo Fisher Scientific, Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Merck KGaA

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Eurofins Scientific S.E.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. QIAGEN N.V.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Becton, Dickinson and Company

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Danaher Corporation

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. NeoGenomics, Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Biolog, Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. IEH Laboratories & Consulting Group

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. VWR Corporation

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Altogen Labs

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

        18.1.12. STERIS Plc.

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

                18.1.12.5.2. Product Strategy

                18.1.12.5.3. Channel Strategy

        18.1.13. Dynatec Labs

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

                18.1.13.5.2. Product Strategy

                18.1.13.5.3. Channel Strategy

        18.1.14. Wickham Laboratories Ltd.

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

                18.1.14.5.2. Product Strategy

                18.1.14.5.3. Channel Strategy

        18.1.15. Charles River Laboratories Inc.

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

                18.1.15.5.2. Product Strategy

                18.1.15.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Virology Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Virology Market (Units) Forecast by Region, 2017-2032

Table 3: Global Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 4: Global Virology Market (Units) Forecast by Product Type, 2017-2032

Table 5: Global Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 6: Global Virology Market (Units) Forecast by Application, 2017-2032

Table 7: Global Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 8: Global Virology Market (Units) Forecast by Indication, 2017-2032

Table 9: Global Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Global Virology Market (Units) Forecast by End User, 2017-2032

Table 11: North America Virology Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: North America Virology Market (Units) Forecast by Country, 2017-2032

Table 13: North America Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 14: North America Virology Market (Units) Forecast by Product Type, 2017-2032

Table 15: North America Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 16: North America Virology Market (Units) Forecast by Application, 2017-2032

Table 17: North America Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 18: North America Virology Market (Units) Forecast by Indication, 2017-2032

Table 19: North America Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 20: North America Virology Market (Units) Forecast by End User, 2017-2032

Table 21: Latin America Virology Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: Latin America Virology Market (Units) Forecast by Country, 2017-2032

Table 23: Latin America Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 24: Latin America Virology Market (Units) Forecast by Product Type, 2017-2032

Table 25: Latin America Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 26: Latin America Virology Market (Units) Forecast by Application, 2017-2032

Table 27: Latin America Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 28: Latin America Virology Market (Units) Forecast by Indication, 2017-2032

Table 29: Latin America Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 30: Latin America Virology Market (Units) Forecast by End User, 2017-2032

Table 31: Europe Virology Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 32: Europe Virology Market (Units) Forecast by Country, 2017-2032

Table 33: Europe Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 34: Europe Virology Market (Units) Forecast by Product Type, 2017-2032

Table 35: Europe Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 36: Europe Virology Market (Units) Forecast by Application, 2017-2032

Table 37: Europe Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 38: Europe Virology Market (Units) Forecast by Indication, 2017-2032

Table 39: Europe Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 40: Europe Virology Market (Units) Forecast by End User, 2017-2032

Table 41: East Asia Virology Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 42: East Asia Virology Market (Units) Forecast by Country, 2017-2032

Table 43: East Asia Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 44: East Asia Virology Market (Units) Forecast by Product Type, 2017-2032

Table 45: East Asia Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 46: East Asia Virology Market (Units) Forecast by Application, 2017-2032

Table 47: East Asia Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 48: East Asia Virology Market (Units) Forecast by Indication, 2017-2032

Table 49: East Asia Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 50: East Asia Virology Market (Units) Forecast by End User, 2017-2032

Table 51: South Asia & Pacific Virology Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 52: South Asia & Pacific Virology Market (Units) Forecast by Country, 2017-2032

Table 53: South Asia & Pacific Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 54: South Asia & Pacific Virology Market (Units) Forecast by Product Type, 2017-2032

Table 55: South Asia & Pacific Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 56: South Asia & Pacific Virology Market (Units) Forecast by Application, 2017-2032

Table 57: South Asia & Pacific Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 58: South Asia & Pacific Virology Market (Units) Forecast by Indication, 2017-2032

Table 59: South Asia & Pacific Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 60: South Asia & Pacific Virology Market (Units) Forecast by End User, 2017-2032

Table 61: MEA Virology Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 62: MEA Virology Market (Units) Forecast by Country, 2017-2032

Table 63: MEA Virology Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 64: MEA Virology Market (Units) Forecast by Product Type, 2017-2032

Table 65: MEA Virology Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 66: MEA Virology Market (Units) Forecast by Application, 2017-2032

Table 67: MEA Virology Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 68: MEA Virology Market (Units) Forecast by Indication, 2017-2032

Table 69: MEA Virology Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 70: MEA Virology Market (Units) Forecast by End User, 2017-2032
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 3: Global Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 4: Global Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 5: Global Virology Market Value (US$ Mn) by Region, 2022-2032

Figure 6: Global Virology Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 7: Global Virology Market (Units) Analysis by Region, 2017-2032

Figure 8: Global Virology Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 9: Global Virology Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 10: Global Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 11: Global Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 12: Global Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 13: Global Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 14: Global Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 15: Global Virology Market (Units) Analysis by Application, 2017-2032

Figure 16: Global Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 17: Global Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 18: Global Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 19: Global Virology Market (Units) Analysis by Indication, 2017-2032

Figure 20: Global Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 21: Global Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 22: Global Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 23: Global Virology Market (Units) Analysis by End User, 2017-2032

Figure 24: Global Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 25: Global Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 26: Global Virology Market Attractiveness by Product Type, 2022-2032

Figure 27: Global Virology Market Attractiveness by Application, 2022-2032

Figure 28: Global Virology Market Attractiveness by Indication, 2022-2032

Figure 29: Global Virology Market Attractiveness by End User, 2022-2032

Figure 30: Global Virology Market Attractiveness by Region, 2022-2032

Figure 31: North America Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 32: North America Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 33: North America Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 34: North America Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 35: North America Virology Market Value (US$ Mn) by Country, 2022-2032

Figure 36: North America Virology Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 37: North America Virology Market (Units) Analysis by Country, 2017-2032

Figure 38: North America Virology Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 39: North America Virology Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 40: North America Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 41: North America Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 42: North America Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 43: North America Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 44: North America Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 45: North America Virology Market (Units) Analysis by Application, 2017-2032

Figure 46: North America Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 47: North America Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 48: North America Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 49: North America Virology Market (Units) Analysis by Indication, 2017-2032

Figure 50: North America Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 51: North America Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 52: North America Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 53: North America Virology Market (Units) Analysis by End User, 2017-2032

Figure 54: North America Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 55: North America Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 56: North America Virology Market Attractiveness by Product Type, 2022-2032

Figure 57: North America Virology Market Attractiveness by Application, 2022-2032

Figure 58: North America Virology Market Attractiveness by Indication, 2022-2032

Figure 59: North America Virology Market Attractiveness by End User, 2022-2032

Figure 60: North America Virology Market Attractiveness by Country, 2022-2032

Figure 61: Latin America Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 62: Latin America Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 63: Latin America Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 64: Latin America Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 65: Latin America Virology Market Value (US$ Mn) by Country, 2022-2032

Figure 66: Latin America Virology Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 67: Latin America Virology Market (Units) Analysis by Country, 2017-2032

Figure 68: Latin America Virology Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 69: Latin America Virology Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 70: Latin America Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 71: Latin America Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 72: Latin America Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 73: Latin America Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 74: Latin America Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 75: Latin America Virology Market (Units) Analysis by Application, 2017-2032

Figure 76: Latin America Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 77: Latin America Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 78: Latin America Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 79: Latin America Virology Market (Units) Analysis by Indication, 2017-2032

Figure 80: Latin America Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 81: Latin America Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 82: Latin America Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 83: Latin America Virology Market (Units) Analysis by End User, 2017-2032

Figure 84: Latin America Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 85: Latin America Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 86: Latin America Virology Market Attractiveness by Product Type, 2022-2032

Figure 87: Latin America Virology Market Attractiveness by Application, 2022-2032

Figure 88: Latin America Virology Market Attractiveness by Indication, 2022-2032

Figure 89: Latin America Virology Market Attractiveness by End User, 2022-2032

Figure 90: Latin America Virology Market Attractiveness by Country, 2022-2032

Figure 91: Europe Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 92: Europe Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 93: Europe Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 94: Europe Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 95: Europe Virology Market Value (US$ Mn) by Country, 2022-2032

Figure 96: Europe Virology Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 97: Europe Virology Market (Units) Analysis by Country, 2017-2032

Figure 98: Europe Virology Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 99: Europe Virology Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 100: Europe Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 101: Europe Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 102: Europe Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 103: Europe Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 104: Europe Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 105: Europe Virology Market (Units) Analysis by Application, 2017-2032

Figure 106: Europe Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 107: Europe Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 108: Europe Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 109: Europe Virology Market (Units) Analysis by Indication, 2017-2032

Figure 110: Europe Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 111: Europe Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 112: Europe Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 113: Europe Virology Market (Units) Analysis by End User, 2017-2032

Figure 114: Europe Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 115: Europe Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 116: Europe Virology Market Attractiveness by Product Type, 2022-2032

Figure 117: Europe Virology Market Attractiveness by Application, 2022-2032

Figure 118: Europe Virology Market Attractiveness by Indication, 2022-2032

Figure 119: Europe Virology Market Attractiveness by End User, 2022-2032

Figure 120: Europe Virology Market Attractiveness by Country, 2022-2032

Figure 121: East Asia Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 122: East Asia Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 123: East Asia Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 124: East Asia Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 125: East Asia Virology Market Value (US$ Mn) by Country, 2022-2032

Figure 126: East Asia Virology Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 127: East Asia Virology Market (Units) Analysis by Country, 2017-2032

Figure 128: East Asia Virology Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 129: East Asia Virology Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 130: East Asia Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 131: East Asia Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 132: East Asia Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 133: East Asia Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 134: East Asia Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 135: East Asia Virology Market (Units) Analysis by Application, 2017-2032

Figure 136: East Asia Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 137: East Asia Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 138: East Asia Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 139: East Asia Virology Market (Units) Analysis by Indication, 2017-2032

Figure 140: East Asia Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 141: East Asia Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 142: East Asia Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 143: East Asia Virology Market (Units) Analysis by End User, 2017-2032

Figure 144: East Asia Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 145: East Asia Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 146: East Asia Virology Market Attractiveness by Product Type, 2022-2032

Figure 147: East Asia Virology Market Attractiveness by Application, 2022-2032

Figure 148: East Asia Virology Market Attractiveness by Indication, 2022-2032

Figure 149: East Asia Virology Market Attractiveness by End User, 2022-2032

Figure 150: East Asia Virology Market Attractiveness by Country, 2022-2032

Figure 151: South Asia & Pacific Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 152: South Asia & Pacific Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 153: South Asia & Pacific Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 154: South Asia & Pacific Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 155: South Asia & Pacific Virology Market Value (US$ Mn) by Country, 2022-2032

Figure 156: South Asia & Pacific Virology Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 157: South Asia & Pacific Virology Market (Units) Analysis by Country, 2017-2032

Figure 158: South Asia & Pacific Virology Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 159: South Asia & Pacific Virology Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 160: South Asia & Pacific Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 161: South Asia & Pacific Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 162: South Asia & Pacific Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 163: South Asia & Pacific Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 164: South Asia & Pacific Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 165: South Asia & Pacific Virology Market (Units) Analysis by Application, 2017-2032

Figure 166: South Asia & Pacific Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 167: South Asia & Pacific Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 168: South Asia & Pacific Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 169: South Asia & Pacific Virology Market (Units) Analysis by Indication, 2017-2032

Figure 170: South Asia & Pacific Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 171: South Asia & Pacific Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 172: South Asia & Pacific Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 173: South Asia & Pacific Virology Market (Units) Analysis by End User, 2017-2032

Figure 174: South Asia & Pacific Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 175: South Asia & Pacific Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 176: South Asia & Pacific Virology Market Attractiveness by Product Type, 2022-2032

Figure 177: South Asia & Pacific Virology Market Attractiveness by Application, 2022-2032

Figure 178: South Asia & Pacific Virology Market Attractiveness by Indication, 2022-2032

Figure 179: South Asia & Pacific Virology Market Attractiveness by End User, 2022-2032

Figure 180: South Asia & Pacific Virology Market Attractiveness by Country, 2022-2032

Figure 181: MEA Virology Market Value (US$ Mn) by Product Type, 2022-2032

Figure 182: MEA Virology Market Value (US$ Mn) by Application, 2022-2032

Figure 183: MEA Virology Market Value (US$ Mn) by Indication, 2022-2032

Figure 184: MEA Virology Market Value (US$ Mn) by End User, 2022-2032

Figure 185: MEA Virology Market Value (US$ Mn) by Country, 2022-2032

Figure 186: MEA Virology Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 187: MEA Virology Market (Units) Analysis by Country, 2017-2032

Figure 188: MEA Virology Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 189: MEA Virology Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 190: MEA Virology Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 191: MEA Virology Market (Units) Analysis by Product Type, 2017-2032

Figure 192: MEA Virology Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 193: MEA Virology Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 194: MEA Virology Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 195: MEA Virology Market (Units) Analysis by Application, 2017-2032

Figure 196: MEA Virology Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 197: MEA Virology Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 198: MEA Virology Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 199: MEA Virology Market (Units) Analysis by Indication, 2017-2032

Figure 200: MEA Virology Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 201: MEA Virology Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 202: MEA Virology Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 203: MEA Virology Market (Units) Analysis by End User, 2017-2032

Figure 204: MEA Virology Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 205: MEA Virology Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 206: MEA Virology Market Attractiveness by Product Type, 2022-2032

Figure 207: MEA Virology Market Attractiveness by Application, 2022-2032

Figure 208: MEA Virology Market Attractiveness by Indication, 2022-2032

Figure 209: MEA Virology Market Attractiveness by End User, 2022-2032

Figure 210: MEA Virology Market Attractiveness by Country, 2022-2032

Recommendations

Healthcare

Virology Specimen Collection Market

Published : October 2022

Explore Healthcare Insights

View Reports